The National Institute of Health has opened enrollment for trials to evaluate potential treatments for long COVID. It's something that long COVID patients and advocates have been calling on for months after the NIH received more than a billion dollars from Congress to research the virus. The trials will test treatments that target the persistence of the Corona virus in the body and cognitive dysfunction related to long COVID.